Â
Latest Cell Banking Outsourcing Companies Update:
Wuxi Apptec Acquires AA Pharma Services: This October 2023 acquisition strengthens Wuxi's leadership in cell banking and cell therapy development, providing a broader range of sevices to clients.
Lonza Partners with CELLINK: This December 2023 collaboration focuses on developing bioprinting solutions for stem cell banking and regenerative medicine applications.
Sartorius Launches New Automated Cell Banking System: In November 2023, Sartorius unveiled their CellGen® Pro platform, offering automation and improved efficiency for large-scale cell banking workflows.
Thermo Fisher Introduces AI-Powered Cell Selection Technology: This innovative technology optimizes selection of desired cell types, enhancing downstream applications like cell therapy.
Cryocell International Enters Pet Stem Cell Banking Market: Recognizing the growing demand, Cryocell launched its "Pawsibilities" program in October 2023 for pet stem cell banking and future potential pet therapies.
Lonza Focuses on Biobanking Solutions for Personalized Medicine: By offering customized storage and management solutions, Lonza caters to the increasing demand for personalized medicine and regenerative medicine therapies.
List of Cell Banking Outsourcing Key companies in the market
- CordLife (Singapore)
- Cleancells (France)
- Charles River Laboratories (US)
- BSL Bioservice (Germany)
- BioReliance (US)
- Sartorius (Germany)
- Covance (US)
- LifeCell International Pvt. Ltd. (India)
- Goodwin Biotechnology Inc.(US)
- GlobalStem Inc.(US)
- , Cryo-Cell International Inc. (US)
- Lonza (Switzerland)
- PX’TherapeuticsSA (France)
- Wuxi Apptec (China)
- SGS Life Sciences (Switzerland)